Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$123.8 - $132.96 $2.23 Million - $2.39 Million
-17,975 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $779,353 - $873,604
-10,602 Reduced 37.1%
17,975 $1.38 Million
Q3 2021

Oct 19, 2021

BUY
$71.68 - $78.83 $2.05 Million - $2.25 Million
28,577 New
28,577 $1.99 Million
Q2 2021

Jul 13, 2021

BUY
$70.31 - $77.77 $0 - $0
0 New
0 $2.06 Million
Q2 2021

Jul 12, 2021

SELL
$70.31 - $77.77 $1.68 Million - $1.86 Million
-23,907 Closed
0 $2.06 Million
Q1 2021

Apr 21, 2021

BUY
$68.86 - $81.11 $1.65 Million - $1.94 Million
23,907 New
23,907 $1.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fulcrum Asset Management LLP Portfolio

Follow Fulcrum Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Asset Management LLP with notifications on news.